Warning letterPosted June 16, 2026

FDA warning letter to Altru Telehealth, LLC dba Altru Telehealth

False & Misleading Claims/Misbranded (Telehealth)

FDA's record ↗

FDA posted a warning letter to Altru Telehealth, LLC dba Altru Telehealth on June 16, 2026; the letter is dated June 8, 2026. Subject: False & Misleading Claims/Misbranded (Telehealth). Issuing office: Center for Drug Evaluation and Research (CDER).

On the record

Company
Altru Telehealth, LLC dba Altru Telehealth
Subject
False & Misleading Claims/Misbranded (Telehealth)
Issuing office
Center for Drug Evaluation and Research (CDER)
Letter dated
2026-06-08
Posted by FDA
2026-06-16
Source
FDA warning letters ↗

The full record

An account shows the violations FDA described and each CFR section it cited.

What a warning letter is

A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.

More

Watch Altru Telehealth, LLC dba Altru Telehealth

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA warning letters. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Altru Telehealth, LLC dba Altru Telehealth.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.